Max Mitteregger
Net worth: 7 M $ as of 2026-05-30
Net worth: 7 M $ as of 2026-05-30
Mr. Max H.
Mitteregger is a Founder & Owner at Max Mitteregger Kapitalförvaltning AB. He is on the Board of Directors at Max Mitteregger Kapitalförvaltning AB.
He has about 25 years of experience working in the financial sector, including as a partner, one of the founders and Head of Equity Sales at ABG Sundal Collier and Head of Sales at Carnegie.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
Humana AB
Humana AB Other Consumer ServicesConsumer Services Offers individual and family care services, personal assistance, and elderly care 2.25% | 2024-12-30 | 1,165,000 ( 2.25% ) | 7 M $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
Max Mitteregger Kapitalförvaltning AB
Max Mitteregger Kapitalförvaltning AB Investment ManagersFinance MMK aims to over time and with a balanced risk-taking give the shareholders an absolute return on invested capital, regardless of the general market. The firm invests the Fund in long positions that are expected to increase in value and short positions that are expected to decrease in value. The fund’s assets are invested in transferable securities, money market instruments, derivatives (including OTC derivatives), exchange traded funds (known as ETFs) and on account with credit institutes. | Founder | 2004-11-23 |
Galba Holding AB | Chief Executive Officer | - |
| Companies | Position | End |
|---|---|---|
| LIDDS AB | Director/Board Member | 2023-07-01 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 3 |
|---|---|
Max Mitteregger Kapitalförvaltning AB
Max Mitteregger Kapitalförvaltning AB Investment ManagersFinance MMK aims to over time and with a balanced risk-taking give the shareholders an absolute return on invested capital, regardless of the general market. The firm invests the Fund in long positions that are expected to increase in value and short positions that are expected to decrease in value. The fund’s assets are invested in transferable securities, money market instruments, derivatives (including OTC derivatives), exchange traded funds (known as ETFs) and on account with credit institutes. | Finance |
LIDDS AB
LIDDS AB Pharmaceuticals: MajorHealth Technology Focuses on the development of treatment alternatives and hormonal therapy for prostate cancer | Health Technology |
Galba Holding AB |
Select your edition
All financial news and data tailored to specific country editions